Navigation Links
Joint Commission International Achieves Accreditation from ISQua

OAK BROOK, Ill., Jan. 3 /PRNewswire-USNewswire/ -- Joint Commission International (JCI) today announced its accreditation by the International Society for Quality in Health Care. JCI is a division of Joint Commission Resources, Inc. (JCR), a private, not-for-profit affiliate of The Joint Commission.

JCI is a global leader in health care accreditation and since 1999 has accredited more than 140 hospitals in 27 countries. This external endorsement by ISQua is a milestone achievement that demonstrates the quality of JCI's accreditation services.

ISQua, a non-profit, independent organization with members in more than 70 countries, is known as the accreditor of accrediting bodies. Accreditation by ISQua provides assurance that the standards, training and processes used by JCI to survey the performance of health care organizations meet the highest international benchmarks for accreditation entities.

"I'm proud to announce JCI's accreditation by ISQua. It demonstrates the dedication and commitment of our Board, staff and surveyors to improving health care quality and safety through the process of accreditation and it allows us to provide external validation of this commitment to our clients," says Karen H. Timmons, CEO, Joint Commission International.

Joint Commission International chose to pursue ISQua accreditation because:

-- It provides confidence and credibility through formal worldwide recognition that an organization meets international standards specifically developed and tested for health care external evaluation bodies, and

-- It involves an impartial and independent review system.

Accreditation by ISQua was a two-part process that touched upon every aspect of how JCI operates. The first part of the process, completed in 2005, involved applying for accreditation, an evaluation of JCI's accreditation standards based on a set of principles created by ISQua, and a self-evaluation by JCI of its compliance with ISQua's standards. The self-evaluation process included everything from the JCI accreditation application process to the deployment of surveyors to JCI's human resources practices, finances and quality improvement processes. JCI spent a year preparing the detailed self-evaluation report and other documents required for submission prior to the arrival of the survey team. The second phase concluded in July with the on-site survey.

For more information about JCI, please visit or call 1.630.268.7400.

Joint Commission International (JCI) was established in 1997 as a division of Joint Commission Resources, Inc. (JCR), a private, not-for-profit affiliate of The Joint Commission. Through international accreditation, consultation, publications and education programs, JCI extends The Joint Commission's mission worldwide by helping to improve the quality of patient care by assisting international health care organizations, public health agencies, health ministries and others evaluate, improve and demonstrate the quality of patient care and enhance patient safety in more than 60 countries.

SOURCE Joint Commission International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
2. Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide
3. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
4. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
5. The impact of physical activity on weight-bearing knee joint
6. Joint Center Says New Approach Required to Reduce Black Infant Mortality
7. Merlyn Medical Announces FDA Approval for FlexWarmer in a Joint Agreement with Elltec and Suzuken
8. The Joint Commission Enhances Quality Check Website
9. OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction
10. More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints
11. Delaware Court Approves Bioenvision, Genzyme Joint Petition
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... 2017 , ... Planet Fitness, one of the largest and fastest growing franchisors ... a flagship location in Covington, LA at 401 N. U.S. Highway 190, in January ... Office Depot in the Holiday Square shopping center. Its location allows it to serve ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: